4 projets européens trouvés
Recherche sur 125080 projets européens
TERMINÉ
Standardization and Development of Assays for Assessment of Influenza Vaccines Correlates of Protection (FLUCOP)
Date du début: 1 mars 2015, Date de fin: 29 févr. 2020,
Background: Influenza viruses cause annual epidemic and occasional pandemics, both of which induce significant morbidity and mortality. Influenza infections affect all age groups but children and adults over the age of 65 are at most risk of developing severe disease.Vaccination is the most effective approach to reduce the impact of annual influenza outbreaks and potential pandemics, however, the ...
Voir le projet
26
Participants partenaires
TERMINÉ
Long-term effects of early nutrition on later health (EARLYNUTRITION)
Date du début: 1 févr. 2012, Date de fin: 31 oct. 2017,
Nutrition during early development has an important impact on later health, particularly through greater obesity risk, as demonstrated by FP6 EARNEST. EarlyNutrition explores the current key hypotheses on likely causes and pathways to prevention of early life origins of obesity (specifically adiposity) and associated disorders. We bring extraordinary expertise and study populations of 470,000 indi ...
Voir le projet
40
Participants partenaires
TERMINÉ
Model-Based Social Learning for Public Administrations (Learn PAd)
Date du début: 1 févr. 2014, Date de fin: 31 oct. 2016,
In modern society public administrations (PAs) are undergoing a transformation of their perceived role from controllers to proactive service providers, and are under pressure to constantly improve their service quality while coping with quickly changing context (changes in law and regulations, societal globalization, fast technology evolution) and decreasing budgets. Civil servants are challenged ...
Voir le projet
9
Participants partenaires
TERMINÉ
Attention Deficit Hyperactivity Disorder Drugs Use Chronic Effects (ADDUCE)
Date du début: 1 nov. 2010, Date de fin: 30 avr. 2016,
Attention deficit hyperactivity disorder (ADHD) is one of the most common neurodevelopmental disorders in children, affecting approximately 5% children in Europe. Methylphenidate (MPH) is the most-commonly prescribed medication for ADHD children; it is also increasingly used in ADHD adults. In 2007, the European Commission requested a referral to the Committee for Medicinal Products for Human Use ...
Voir le projet